Health ❯ Healthcare

Patient Care

Treatment Options Hospitalization Emergency Services Chronic Conditions Quality of Life Chronic Illness Diagnosis Chronic Illness Management Access to Care Treatment Efficacy

20,000 New York Nurses Issue Strike Notices at 15 Hospitals

Talks continue during the 10-day notice period, with hospitals warning of costly contingency plans.

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Stories older than 24h

Blood Centers Push for Donors After Holiday Dip as Red Cross Dangles Super Bowl Trip

FDA Grants Priority Review to Axsome’s AXS-05 for Alzheimer’s Agitation, Sets April 30 PDUFA Date

FDA Issues Complete Response Letter for Corcept’s Relacorilant in Cushing’s-Related Hypertension

Statins Cut Deaths and Major Cardiac Events Across Risk Levels in Type 2 Diabetes

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

NYC Health + Hospitals to Merge With Maimonides by April 2026 Pending Approvals

Greg Papa Declines Return to 49ers Radio Booth for Bears Game

FDA Approves First Oral Weight-Loss GLP-1: Wegovy Pill to Launch in January

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Aqvesme for Thalassemia Anemia, First U.S. Therapy for Both Patient Groups

Longitudinal Study Finds One in Four U.S. Adults Faces Unaffordable Care or Skips Treatment

Donor Support Expands Santa's Visit at Teddy's Place NICU in Annapolis

Neurocrine’s Valbenazine Misses Phase 3 Goals in Dyskinetic Cerebral Palsy

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Mount Sinai's NutriSighT Predicts Underfeeding Risk in Ventilated ICU Patients

FDA Grants Accelerated Approval to Subcutaneous Lunsumio for Relapsed Follicular Lymphoma

Large Swedish Study Finds ARBs Sustain the Best Long-Term Adherence in Hypertension

FDA Approves Cytokinetics’ Myqorzo for Obstructive Hypertrophic Cardiomyopathy